These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16823908

  • 1. Reverse vaccinology--in search of a genome-derived meningococcal vaccine.
    Danzig L.
    Vaccine; 2006 Apr 12; 24 Suppl 2():S2-11-2. PubMed ID: 16823908
    [Abstract] [Full Text] [Related]

  • 2. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
    Bai X, Borrow R.
    Expert Rev Vaccines; 2010 Oct 12; 9(10):1203-17. PubMed ID: 20923270
    [Abstract] [Full Text] [Related]

  • 3. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
    Masignani V, Pizza M, Moxon ER.
    Front Immunol; 2019 Oct 12; 10():751. PubMed ID: 31040844
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
    Su EL, Snape MD.
    Expert Rev Vaccines; 2011 May 12; 10(5):575-88. PubMed ID: 21604979
    [Abstract] [Full Text] [Related]

  • 8. Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease.
    Watson PS, Novy PL, Friedland LR.
    Int J Infect Dis; 2019 Aug 12; 85():22-27. PubMed ID: 31102824
    [Abstract] [Full Text] [Related]

  • 9. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation.
    Brehony C, Rodrigues CMC, Borrow R, Smith A, Cunney R, Moxon ER, Maiden MCJ.
    Vaccine; 2016 Sep 07; 34(39):4690-4697. PubMed ID: 27521232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL, van den Dobbelsteen GP, de Groot R.
    Curr Opin Mol Ther; 2003 Feb 07; 5(1):33-8. PubMed ID: 12669468
    [Abstract] [Full Text] [Related]

  • 12. Neisseria meningitidis B vaccines.
    Panatto D, Amicizia D, Lai PL, Gasparini R.
    Expert Rev Vaccines; 2011 Sep 07; 10(9):1337-51. PubMed ID: 21919622
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
    Lucidarme J, Lekshmi A, Parikh SR, Bray JE, Hill DM, Bratcher HB, Gray SJ, Carr AD, Jolley KA, Findlow J, Campbell H, Ladhani SN, Ramsay ME, Maiden MCJ, Borrow R.
    J Infect; 2017 Aug 07; 75(2):95-103. PubMed ID: 28579305
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.
    Mowlaboccus S, Perkins TT, Smith H, Sloots T, Tozer S, Prempeh LJ, Tay CY, Peters F, Speers D, Keil AD, Kahler CM.
    PLoS One; 2016 Aug 07; 11(6):e0158315. PubMed ID: 27355628
    [Abstract] [Full Text] [Related]

  • 17. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
    Villena R, Safadi MAP, Valenzuela MT, Torres JP, Finn A, O'Ryan M.
    Hum Vaccin Immunother; 2018 May 04; 14(5):1042-1057. PubMed ID: 29667483
    [Abstract] [Full Text] [Related]

  • 18. A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.
    Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, Jansen KU, Perez JL.
    Pediatr Infect Dis J; 2013 Apr 04; 32(4):364-71. PubMed ID: 23114369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential.
    Hung MC, Heckels JE, Christodoulides M.
    mBio; 2013 Feb 26; 4(2):. PubMed ID: 23443003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.